ACMI - Accumed Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sigmund who wrote (733)	12/23/1997 4:49:00 AM
From: Steven Zimmer	Read Replies (1) of 1894

Hi Sigmund May I suggest that I have also heard from other sources that the Cytc ThinPrep is not what is cracked up to be. There may be some studies emerging from a prominent French Laboratory that ThinPrep advantages are not sufficient to justify the cost. However, as far as ACMI is concerned, whether ThinPrep works or not is irrelevent as they have been able to show that their instrument has a significant impact on Cytopath lab productivity and, hence, profitability. If ThinPrep is what it is cracked up to be, all the better given the data that ACMI has generated. I have met with Gombrich recently and he is extremely upbeat about the company. So much so that he claims to be buying the stock at these prices! Greetings

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next